Sign up for free newsletter



SPDR S&P Biotech ETF receives settlement payment

Wed, 20/08/2014 - 06:01

State Street Global Advisors’ SPDR S&P Biotech ETF has received a payment as an authorised claimant from a class action settlement related to Dendreon Corp.

The total amount payable to the fund is USD233,312.
When the fund calculates its net asset value (NAV) per share on 19 August it is estimated that the fund’s NAV will be impacted by USD0.0311 for each of the existing 7,500,000 shares.

Subscribe to free daily newsletter
from ETF Express

SIX Swiss Exchange lists 1000th ETF

Wed 25/02/2015 - 06:00

Reasons to be bearish on oil

Mon 16/02/2015 - 18:26

Deutsche Bank to redeem six ETNs

Mon 16/02/2015 - 12:00

Interest Rate Sales - NA Investment Bank

Tue, 03 Mar 2015 00:00:00 GMT

Junior Quantitative Research | Systematic trading

Tue, 03 Mar 2015 00:00:00 GMT

PHD Software Engineers/Quantitative Engineers

Tue, 03 Mar 2015 00:00:00 GMT

1 day 11 hours from now - London
1 day 11 hours from now - San Francisco
5 days 11 hours from now - Boston